Amgen

Big Pharma's Shoes Don't Fit Amgen
Bloomberg
Tue, 11/10/15 - 09:38 am
Amgen
Big Pharma
What Companies Amgen May Be Eyeing For M&A?
Bidness, ETC
Tue, 11/10/15 - 08:29 am
Amgen
M&A
Seattle Genetics
Alnylam
Dr Reddy's
Cytokinetics, Amgen drug shows promise in heart failure study
Yahoo/Reuters
Mon, 11/9/15 - 10:28 am
Amgen
Cytokinetics
omecamtiv
chronic heart failure
Amgen’s Late-Stage Pipeline Continues to Advance in 3Q15
Yahoo/Market Realist
Wed, 11/4/15 - 02:06 pm
Amgen
Amgen’s Oncology Drugs Register Solid Growth In 3Q15
Yahoo/Market Realist
Tue, 11/3/15 - 02:18 pm
Amgen
earnings
Drugmaker Amgen posts big increases in 3Q profit, sales
Yahoo/AP
Wed, 10/28/15 - 06:19 pm
Amgen
earnings
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Forbes
Wed, 10/28/15 - 09:17 am
Amgen
Imlygic
T-Vec
blood cancer
Amgen's First-of-its-Kind Skin Cancer Drug Wins U.S. Approval
Bloomberg
Tue, 10/27/15 - 09:25 pm
Amgen
T-Vec
melanoma
Amgen, Cytokinetics heart failure drug succeeds in mid-stage study
Yahoo/Reuters
Tue, 10/27/15 - 09:56 am
Amgen
Cytokinetics
Omecamtiv Mecarbil
chronic heart failure
Amgen Q3 Earnings: Here’s What To Expect
Bidness, ETC
Tue, 10/27/15 - 09:54 am
Amgen
earnings
Amgen reviews privacy of patient assistance program for cholesterol drug
Pharmalot
Mon, 10/26/15 - 04:36 pm
Amgen
Repatha
patient assistance programs
Amgen's T-Vec inches toward EU approval for melanoma
Fierce Biotech
Fri, 10/23/15 - 11:06 am
Amgen
T-Vec
melanoma
Europe
PCSK9 drugmakers go Big Data to ID more eligible patients
Fierce Pharma Marketing
Wed, 10/21/15 - 11:34 am
PCSK9 inhibitors
patients
Big Data
Amgen
Sanofi
Regeneron
Repatha
Praluent
Amgen's Innovation Counters Biosimilar Pressure
Morningstar
Mon, 10/19/15 - 10:03 am
Amgen
innovation
biosimilars
Epogen
Aranesp
Neupogen
Did Amgen Waste $300 Million In Buying A Flawed Heart Drug?
Forbes
Mon, 10/12/15 - 01:39 pm
Amgen
Eli Lilly
evacetrapib
CETP inhibitors
Dezima
TA-8995
Lilly Loses Its Bloom; Amgen, Regeneron Blossom
Barron's
Mon, 10/12/15 - 11:51 am
Eli Lilly
Amgen
Regeneron
evacetrapib
Repatha
Amgen Was Clobbered in September -- Here's Why
Motley Fool
Fri, 10/9/15 - 10:08 am
Amgen
Repatha
drug pricing
Amgen Turning the Tables on 'Generic' Competition
Motley Fool
Wed, 10/7/15 - 09:59 am
Amgen
biosimilars
generics
patents
R&D
Express Scripts to Cover Both New Cholesterol Drugs
NASDAQ.com
Tue, 10/6/15 - 07:00 pm
Express Scripts
Praluent
Repatha
PCSK9 inhibitors
Sanofi
Amgen
Regeneron
Analyst sees big things for Allergan, Amgen despite slow growth in China and biosimilar pressures
Fierce Pharma
Fri, 10/2/15 - 04:54 pm
Allergan
Amgen

Pages